Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid

MLA

Norbert Mueller, et al. “Celecoxib Augmentation of Escitalopram in Treatment-Resistant Bipolar Depression and the Effects on Quinolinic Acid.” Neurology, Psychiatry and Brain Research, vol. 32, June 2019, pp. 22–29. EBSCOhost, https://doi.org/10.1016/j.npbr.2019.03.005.

APA

Norbert Mueller, Natalie Moll, Elif Weidinger, Angelos Halaris, Brendan Martin, Gregor Schütze, Bianca Burger, Stephen Murata, Markus J. Schwarz, & Monica Feliz R. Castillo. (2019). Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid. Neurology, Psychiatry and Brain Research, 32, 22–29. https://doi.org/10.1016/j.npbr.2019.03.005

Chicago

Norbert Mueller, Natalie Moll, Elif Weidinger, Angelos Halaris, Brendan Martin, Gregor Schütze, Bianca Burger, Stephen Murata, Markus J. Schwarz, and Monica Feliz R. Castillo. 2019. “Celecoxib Augmentation of Escitalopram in Treatment-Resistant Bipolar Depression and the Effects on Quinolinic Acid.” Neurology, Psychiatry and Brain Research 32 (June): 22–29. doi:10.1016/j.npbr.2019.03.005.